
Midatech Pharma plc MTP
Geschäftsbericht 2024
hinzugefügt 07.02.2026
Midatech Pharma plc Finanzkreislauf 2011-2026 | MTP
Finanzkreislauf Jährlich Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 82.8 | -8.54 K | - | - | - | - |
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 82.8 | -8.54 K | -4.23 K |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
ANI Pharmaceuticals
ANIP
|
235 | $ 80.34 | -1.83 % | $ 1.55 B | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.84 | 3.54 % | $ 4.58 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
53.8 | $ 2.67 | 1.52 % | $ 150 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Akebia Therapeutics
AKBA
|
86 | $ 1.5 | 7.91 % | $ 281 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Compugen Ltd.
CGEN
|
-123 | $ 1.71 | 2.4 % | $ 153 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
-186 | $ 41.31 | 1.18 % | $ 4.26 B | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Catalyst Pharmaceuticals
CPRX
|
54.2 | $ 24.45 | 0.04 % | $ 2.9 B | ||
|
Cardiff Oncology
CRDF
|
284 | $ 1.58 | -1.25 % | $ 75.3 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 49.7 | 1.97 % | $ 4.19 B | ||
|
Champions Oncology
CSBR
|
1.94 | $ 6.55 | - | $ 89.5 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.52 | - | $ 4.49 B |